Tumor vaccines for breast cancer. [Cancer Invest. 2009] - PubMed

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2. [J Transl Med. 2007]
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM. J Transl Med. 2007 Sep 6; 5:42. Epub 2007 Sep 6.
Immunizing against breast cancer: a new swing for an old sword. [Breast. 2009]
Immunizing against breast cancer: a new swing for an old sword.
Curigliano G, Locatelli M, Fumagalli L, Goldhirsch A. Breast. 2009 Oct; 18 Suppl 3:S51-4.
Cancer vaccines: finding the best way to train the immune system. [J Natl Cancer Inst. 2002]
Cancer vaccines: finding the best way to train the immune system.
Goldman B. J Natl Cancer Inst. 2002 Oct 16; 94(20):1523-6.
Review The immune response to breast cancer, and the case for DC immunotherapy. [Cytotherapy. 2004]
Review The immune response to breast cancer, and the case for DC immunotherapy.
Allan CP, Turtle CJ, Mainwaring PN, Pyke C, Hart DN. Cytotherapy. 2004; 6(2):154-63.
Review [Anti-HER2 vaccines: The HER2 immunotargeting future?]. [Pathol Biol (Paris). 2011]
Review [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I. Pathol Biol (Paris). 2011 Jun; 59(3):173-82. Epub 2009 May 28.

Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer. [Cancer Res Treat. 2011]
Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.
Park MH, Yang DH, Kim MH, Jang JH, Jang YY, Lee YK, Jin CJ, Pham TN, Thi TA, Lim MS, et al. Cancer Res Treat. 2011 Mar; 43(1):56-66. Epub 2011 Mar 31.
Review Current status of mucins in the diagnosis and therapy of cancer. [Biofactors. 2009]
Review Current status of mucins in the diagnosis and therapy of cancer.
Rachagani S, Torres MP, Moniaux N, Batra SK. Biofactors. 2009 Nov-Dec; 35(6):509-27.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Tumor vaccines for breast cancer.
Tumor vaccines for breast cancer.
Cancer Invest. 2009 May ;27(4):361-8.

PubMed
Percutaneous controlled radiofrequency rhizotomy in the management of patients w...
Percutaneous controlled radiofrequency rhizotomy in the management of patients with trigeminal neuralgia due to multiple sclerosis.
Acta Neurochir (Wien). 2000 ;142(6):685-9; discussion 689-90.

PubMed
Bisphosphonate use in chronic kidney disease: association with adynamic bone dis...
Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
Blood Purif. 2010 ;29(3):293-9. Epub 2010 Jan 21 .

PubMed
Human herpesvirus 2, complete genome
Human herpesvirus 2, complete genome
gi|9629267|ref|NC_001798.1||gnl|NCB OMES|12163

Nucleotide
Interferon-beta signaling is enhanced in patients with insufficient coronary col...
Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
Circ Res. 2008 May 23 ;102(10):1286-94. Epub 2008 Apr 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed